186 related articles for article (PubMed ID: 4138143)
21. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
Koestler TP; Papsidero LD; Nemoto T; Chu TM
Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
[TBL] [Abstract][Full Text] [Related]
22. Immunity and cancer.
Barg S; Levin M; Rezzonico R
Int Adv Surg Oncol; 1981; 4():337-47. PubMed ID: 7251176
[No Abstract] [Full Text] [Related]
23. [Distribution of so-called Thomsen-Friedenreich antigens in normal, diseased and carcinomatous breast tissue].
Klein PJ; Newman RA; Müller P; Schaefer HE; Lennartz KJ; Uhlenbruck G; Fischer R
Verh Dtsch Ges Pathol; 1978; 62():325. PubMed ID: 746856
[No Abstract] [Full Text] [Related]
24. [Cellular immunity in patients with melanoma].
Gorodinova VV; Kholenshed A; Babakova SV
Vopr Onkol; 1976; 22(12):3-5. PubMed ID: 1020253
[TBL] [Abstract][Full Text] [Related]
25. Human breast cancer. A model for cancer immunology.
Black MM
Isr J Med Sci; 1973 Mar; 9(3):284-99. PubMed ID: 4575653
[No Abstract] [Full Text] [Related]
26. Immunologic responses in cancer patients.
Solowey AC; Rapaport FT
Surg Gynecol Obstet; 1965 Oct; 121(4):756-60. PubMed ID: 5838283
[No Abstract] [Full Text] [Related]
27. [Organospecific antigen of the mammary gland in human mammary gland cancer and its metastases].
Karamova ER
Vopr Onkol; 1967; 13(8):97-103. PubMed ID: 5601556
[No Abstract] [Full Text] [Related]
28. [Immunological cell-type reaction in patients with and without malignant tumors].
Pavelić Z; Boranić M; Milas L
Lijec Vjesn; 1973 Feb; 95(2):62-7. PubMed ID: 4121020
[No Abstract] [Full Text] [Related]
29. The chemical nature of cancer basic protein.
Dickinson JP; Caspary EA
Br J Cancer Suppl; 1973 Aug; 1():224-8. PubMed ID: 4804282
[TBL] [Abstract][Full Text] [Related]
30. Comparison of rates of phenotypic variability in surface antigen expression in normal and cancerous human breast epithelial cells.
Peterson JA; Ceriani RL; Blank EW; Osvaldo L
Cancer Res; 1983 Sep; 43(9):4291-6. PubMed ID: 6347369
[TBL] [Abstract][Full Text] [Related]
31. Recovery of immunologically reactive antibodies and antigens from breast cancer immune complexes by preparative isoelectric focusing.
Maidment BW; Papsidero LD; Nemoto T; Chu TM
Cancer Res; 1981 Mar; 41(3):795-800. PubMed ID: 7459866
[TBL] [Abstract][Full Text] [Related]
32. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer.
Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696
[No Abstract] [Full Text] [Related]
33. Delayed cutaneous hypersensitivity reactions to concanavalin A-binding tumour membrane components.
Cunningham TJ; Weber PB; Teitelbaum HD; Blumenstock FA; Charniga C
Clin Exp Immunol; 1975 Jul; 21(1):97-100. PubMed ID: 1181077
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and MuMTV-like antigenicity of human breast cancer tissues.
Black MM
Contemp Top Immunobiol; 1977; 6():239-62. PubMed ID: 194749
[No Abstract] [Full Text] [Related]
35. Nasopharyngeal carcinoma membrane soluble antigen.
Tsukuda M; Sawaki S; Yanoma S; Yoshimura N; Takei M; Takada M; Sudo K; Suzuki K; Kawamura A
Jpn J Exp Med; 1980 Feb; 50(1):79-84. PubMed ID: 6155484
[No Abstract] [Full Text] [Related]
36. Proceedings: Membrane-related antigens in pleural fluids of patients with breast cancer.
Gorsky Y; Sulitzeanu D
Isr J Med Sci; 1975 Dec; 11(12):1399-1400. PubMed ID: 1218999
[No Abstract] [Full Text] [Related]
37. A possible role for cross-reacting antigens in conditioning immunological surveillance mechanisms in cancer and transplantation. II. Prospective studies of altered cellular immune reactivity in cancer patients.
Rapaport FT; Lawrence HS
Transplant Proc; 1975 Jun; 7(2):281-5. PubMed ID: 1129846
[No Abstract] [Full Text] [Related]
38. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
Bloom ET
Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
[No Abstract] [Full Text] [Related]
39. Cellular immunity to breast carcinoma and malignant melanoma.
Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
[TBL] [Abstract][Full Text] [Related]
40. [Delayed hypersensitivity reaction in malignant melanoma].
Gorodilova VV; Saraeva ZM; Slesareva RI; Monzul' GD
Vopr Onkol; 1973; 19(3):23-7. PubMed ID: 4762691
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
